AKT PROTEIN KINASE INHIBITORS

The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the c...

Full description

Saved in:
Bibliographic Details
Main Authors MILLER SCOTT, XIAO DENGMING, BLAKE JAMES, PISCOPIO ANTHONY, XU RIU, WANG BIN, SPENCER KEITH L, MUNSON MARK, VIGERS GUY P. A, MITCHELL IAN S, RAO CHANG, HAN YONGXIN, JOSEY JOHN, KALLAN NICHOLAS C, STENGEL PETER, BERNACKI APRIL L
Format Patent
LanguageEnglish
Korean
Published 23.12.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
AbstractList The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Author PISCOPIO ANTHONY
SPENCER KEITH L
STENGEL PETER
BLAKE JAMES
JOSEY JOHN
RAO CHANG
BERNACKI APRIL L
WANG BIN
MILLER SCOTT
XIAO DENGMING
MITCHELL IAN S
XU RIU
MUNSON MARK
VIGERS GUY P. A
KALLAN NICHOLAS C
HAN YONGXIN
Author_xml – fullname: MILLER SCOTT
– fullname: XIAO DENGMING
– fullname: BLAKE JAMES
– fullname: PISCOPIO ANTHONY
– fullname: XU RIU
– fullname: WANG BIN
– fullname: SPENCER KEITH L
– fullname: MUNSON MARK
– fullname: VIGERS GUY P. A
– fullname: MITCHELL IAN S
– fullname: RAO CHANG
– fullname: HAN YONGXIN
– fullname: JOSEY JOHN
– fullname: KALLAN NICHOLAS C
– fullname: STENGEL PETER
– fullname: BERNACKI APRIL L
BookMark eNrjYmDJy89L5WSQdfQOUQgI8g9x9fRT8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx3kFGBoaGBobG5hbGFo7GxKkCAPPmI7k
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20110137838A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20110137838A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:55:43 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20110137838A3
Notes Application Number: KR20117028995
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111223&DB=EPODOC&CC=KR&NR=20110137838A
ParticipantIDs epo_espacenet_KR20110137838A
PublicationCentury 2000
PublicationDate 20111223
PublicationDateYYYYMMDD 2011-12-23
PublicationDate_xml – month: 12
  year: 2011
  text: 20111223
  day: 23
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies ARRAY BIOPHARMA, INC
RelatedCompanies_xml – name: ARRAY BIOPHARMA, INC
Score 2.7956898
Snippet The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title AKT PROTEIN KINASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111223&DB=EPODOC&locale=&CC=KR&NR=20110137838A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFPVNpzJ1k4LSt-C6tF33UGT9RetYW7oqextp04IobriK_77XsOqe9hYSuCQHl-_ukvsC8DDQOFd4xoleDjSilnxIWJYppKC5pjGVclWQPc9C3X9RnxfaogUfTS2M4An9EeSIaFE52nslzuv1fxLLEW8rN4_ZG3atnrzUdGTepPsUhDvZsUw3jpzIlm3bnCZymIixml3PoMbkAA7RkR7V9uC-WnVdynoXVLwzOIpR3md1Dq33VQdO7ObvtQ4cz7ZX3tjcWt_mAvrokElxEqVuEEoYdk_mrhSEfmAFaZTML-Hec1PbJzjP8m9by2myuyh6BW0M-IsuSKqRl6hCvURnRh1zxlip0WI01hnqE9HlGnr7JN3sH76FU5EXVYZkSHvQrr6-iz4Ca5XdCX38AjOCeE8
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq-Kj1YCSW7B5mh6CNC8S0zxIo_RWNtkERLHFRvz7TpZGe-pt2YHZ3YHZeezONwD3I5VSkeZU0KqRKigVlQSS56JQyoWqEkWmCgN7DiPNe1Ge5-q8Ax9tLQzDCf1h4IioUQXqe83u69V_EstmfyvXD_kbTi2f3Mywedqm-0Q0d7xtGk4S27HFW5YRpHyUMlqDrqfL-mQP9tHJ1pt-B86r2dSlrLaNinsMBwny-6xPoPO-7EPPanuv9eEw3Dx543CjfetTGKJDxiVpnDl-xGHYPZk5nB95vulncTo7gzvXySxPwHUWf8daBOn2puRz6GLAX14Ap-hFhSLUKnRmlDElhFSqXD6ONYLyROtyCYNdnK52k2-h52XhdDH1o-AajliOVJQESR5At_76LodoZOv8hsnmF_9nez8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=AKT+PROTEIN+KINASE+INHIBITORS&rft.inventor=MILLER+SCOTT&rft.inventor=XIAO+DENGMING&rft.inventor=BLAKE+JAMES&rft.inventor=PISCOPIO+ANTHONY&rft.inventor=XU+RIU&rft.inventor=WANG+BIN&rft.inventor=SPENCER+KEITH+L&rft.inventor=MUNSON+MARK&rft.inventor=VIGERS+GUY+P.+A&rft.inventor=MITCHELL+IAN+S&rft.inventor=RAO+CHANG&rft.inventor=HAN+YONGXIN&rft.inventor=JOSEY+JOHN&rft.inventor=KALLAN+NICHOLAS+C&rft.inventor=STENGEL+PETER&rft.inventor=BERNACKI+APRIL+L&rft.date=2011-12-23&rft.externalDBID=A&rft.externalDocID=KR20110137838A